Loading...
•
Jun 30, 2022
Surgery Partners Q2 2022 Earnings Report
Reported a revenue increase of 13.3% and an Adjusted EBITDA increase of 13.4% compared to the prior year period.
Key Takeaways
Surgery Partners, Inc. announced its second quarter 2022 results, with revenue increasing by 13.3% to $615.4 million and Adjusted EBITDA increasing by 13.4% to $86.1 million. The company performed over 149,000 surgical cases, a 7% increase from the prior year. They reaffirmed their 2022 Adjusted EBITDA guidance of $375 million to $385 million and revenue guidance of $2.5 billion to $2.6 billion.
Revenue increased 13.3% from the prior year period to $615.4 million.
Days adjusted same-facility revenues increased 6.9% from the prior year period.
Net loss attributable to common stockholders was $18.4 million.
Adjusted EBITDA increased 13.4% over the prior year period to $86.1 million, inclusive of a $0.1 million benefit from the recognition of CARES Act grants.
Forward Guidance
The Company continues to project 2022 Adjusted EBITDA in the range of $375 million to $385 million and 2022 revenue in the range of $2.5 billion to $2.6 billion.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...